CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Acquisition or sale completed · Other events
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Other events
- 4 Shares withheld for taxes Chief Financial Officer gave up 9,602 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 35,179 shares (to pay taxes)
- 4 Open-market buy Chief Executive Officer bought 25,000 shares at $13.39 ($334,750)
- 4 Open-market buy Chief Financial Officer bought 2,500 shares at $13.54 ($33,850)
- 4 Open-market buy Director bought 25,000 shares at $13.37 ($334,250)
- 4 Open-market buy Director bought 1,860 shares at $13.42 ($24,961)
- CERT Other Certification
- 8-A12B Other Registration of Securities
- 8-K Event Material agreement · New debt or obligation
- 424B5 Offering Prospectus
- 305B2 Other 305B2
- 8-K Event Material agreement · Regulation FD disclosure · Other events
- FWP Offering Free Writing Prospectus
- 424B5 Offering Prospectus
- 4 Open-market buy 10% owner bought 431,183 shares at $10.52 ($4,536,045)
Page 10 of 44 · 872 filings